The literature has shown that miRNA-650 is able to serve as an oncogene and promote cell proliferation by directly targeting large tumor suppressor kinase 2 (LATS2) in non-small cell lung cancer formation and progression [28]. Here, LATS2 is linked to non-small cell lung carcinoma.